|
Informa Life Sciences’ 8th Annual Congress: G Protein-Coupled Receptors
17 March 2010 - 18 March 2010
17- 18 March 2010 • Berlin, Germany
The latest and most exciting developments in biased agonism, in silico modelling, allosterism, signalling & trafficking, structure & mechanism, dimerisation, deorphanisation, screening methodologies and medicinal chemistry.
Visit:
http://www.iir-events.com/IIR-Conf/page.aspx?id=25050&vip=[LabelCode]
|
|
|
|
ADME PK/TK and Drug Metabolism in Drug Discovery and Development
08 April 2010 - 09 April 2010
|
|
|
|
SBS 16th Annual Conference & Exhibition, Phoenix, Arizona, USA
11 April 2010 - 15 April 2010
Advancing the Science of Drug Discovery: More than 2,000 scientists, innovators, researchers and industry analysts from around the world will converge in Phoenix to learn about the latest trends and basic and applied research that are transforming the way new pharmaceuticals are developed.
|
|
|
|
Advances in Cell Culture Technology, 15th April 2010, Welwyn Garden City
15 April 2010 - 16 April 2010
After our very successful ‘Developments in cell culture technology to enhance cell growth in vitro’ meeting that took place May 2008 (the agenda can be viewed at www.euroscicon.com/2ndmay08cellculture.pdf) we are pleased to announce this follow up which will again be chaired by Dr Stefan Przyborski, School of Biological and Biomedical Science, Durham University, UK
The meeting has CPD accreditation.
|
|
|
|
High Throughput Screening
26 April 2010 - 27 April 2010
The theme of this year's conference will be on how to lead HTS down an intelligent route towards lead generation,
looking at a wide range of issues within the HTS arena under several 'topic umbrellas'.
|
|
|
|
Compound Management & Integrity 2010, 17 - 19 May 2010, London Kensington, UK
17 May 2010 - 19 May 2010
The Pharma IQ annual Compound Management & Integrity event is Europe’s flagship event covering the most forward-thinking practices and technology in compound logistics, automation from store to screen, analytical characterisation, outsourcing and how to evolve the value of your library.
|
|
|
|
SBS Biopharmaceuticals Symposium
20 May 2010 - 21 May 2010
|
|
|
|
SBS Biopharmaceuticals Symposium: Exploring Synergies Across Drug Formats
20 May 2010 - 21 May 2010
Biopharmaceuticals is a rapidly growing sector of the pharmaceutical industry. Major pharmaceutical companies have recognized this trend in recent years and defined ambitious targets for the proportion of their pipeline that is expected to be filled by novel biopharmaceuticals. It is inevitable that many of the scientists involved with small-molecule drug discovery will be called upon to contribute their experience to biopharmaceuticals discovery.
|
|
|
|
The 9th Annual Biological Production Forum 2010- Frankfurt, Germany
21 June 2010 - 23 June 2010
The Biological Production Forum will focus on both upstream and downstream processing for biological manufacturing, production and cGMP specialists. Included in the event this year, is the unique opportunity to take part in a tour of Merck KGA’s brand new Process Solutions plant.
|
|
|
|
8th Annual Ion Channel Retreat
28 June 2010 - 30 June 2010
Aurora Biomed invites you to attend the 8th Annual Ion Channel Retreat. The Retreat is a premier conference featuring a wide variety of topics and speakers, providing a forum where scientists can discuss, collaborate, and propel forward ion channel research.
|
|
|
|
RNAi, siRNA and miRNA - Crowne Plaza, London
28 June 2010 - 29 June 2010
This conference brings together the leading experts in the industry and academia to explore the cutting edge of new therapeutics being researched and brought to the marketplace, looking at a wide range of issues within the RNAi arena. It will combine a study of the latest successes in the research and development phase with presentations covering the key themes of delivery, target identification and IP issues
|
|
|
|
ADMET - Crowne Plaza St James Hotel, London, UK
07 July 2010 - 08 July 2010
SMi's 5th Annual ADMET Conference brings together leading experts from the pharmaceutical industry and academia to examine the latest development, technologies and techniques in ADMET.
|
|
|